Enrichment Strategies for Systemic Sclerosis-Interstitial Lung Disease Trials. | Am J Respir Crit Care Med;209(9): 1067-1068, 2024 05 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Enrichment Strategies for Systemic Sclerosis-Interstitial Lung Disease Trials.

Volkmann, Elizabeth R; Tashkin, Donald P.

Affiliation

Volkmann ER; Department of Medicine David Geffen School of Medicine at UCLA Los Angeles, California.
Tashkin DP; Department of Medicine David Geffen School of Medicine at UCLA Los Angeles, California.

Am J Respir Crit Care Med ; 209(9): 1067-1068, 2024 05 01.

Article in En | MEDLINE | ID: mdl-38690975

Subject(s)

Lung Diseases, Interstitial; Scleroderma, Systemic; Humans; Scleroderma, Systemic/therapy; Lung Diseases, Interstitial/therapy; Clinical Trials as Topic; Female; Male

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Lung Diseases, Interstitial Limits: Female / Humans / Male Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2024 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Lung Diseases, Interstitial Limits: Female / Humans / Male Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2024 Type: Article